Subscribe

Imunon, Inc. (IMNN)

USD1.93 -0.04 (-2.03%)
US NASDAQ Healthcare Biotechnology
Address 997 Lenox Drive 8648
Lawrenceville, NJ, US
CEO Stacy R. Lindborg
Website imunon.com
IPO 1999-03-01
CIK 749647 ISIN US15117N7012

Explore sections of this company profile

Also trades on London Stock Exchange · 0HUZ.L (USD) NASDAQ Capital Market · CLSN (USD) NASDAQ Capital Market · IMNN (USD)
Description

Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.93 -0.04 (-2.03%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
52.8K
Beta
1.95
Float Shares
2.49M
Free Float %
98.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.70% -5.80% -12.16% -20.00% -37.50% -31.76% -78.33% -87.12% -98.83% -99.94% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (4 ratings, all time) Buy
Price Targets & DCF
Current price
1.93
Low 10.00 +418.1%
Consensus 10.00 +418.1%
Median 10.00 +418.1%
High 10.00 +418.1%
DCF (Unlevered) 3.08 +59.4%
DCF (Levered) 3.66 +89.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 3 0
Hold 0 -1
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month 1
10.00
+418.1%
Last Quarter 1
10.00
+418.1%
Last Year 1
10.00
+418.1%
All Time 1
10.00
+418.1%
Quality scores
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    +67.6% Q1'26: +77.2% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
    Q1'26: +0.0% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +140.6% Q1'26: +350.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.07× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.03) × ERP
WACC = 85% × Ke + 15% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 3.08 Current price: 1.93
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2015
actual
Dec 2016
actual
Dec 2017
actual
Dec 2018
actual
Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
4 Rev. Ana.
3 EPS Ana.
Dec 2027
4 Rev. Ana.
2 EPS Ana.
Dec 2028
4 Rev. Ana.
3 EPS Ana.
Dec 2029
3 Rev. Ana.
1 EPS Ana.
Dec 2030
3 Rev. Ana.
1 EPS Ana.
Revenue
500.0K
est: 518.8K (-3.6%)
500.0K
est: 500.0K (+0.0%)
500.0K
est: 500.0K (+0.0%)
500.0K
est: 500.0K (+0.0%)
500.0K
est: 440.0K (+13.6%)
500.0K
est: 500.0K (+0.0%)
500.0K
est: 458.3K (+9.1%)
500.0K
est: 500.0K (+0.0%)
est: 62.5K (-100.0%)
est: 10.43M (-100.0%)
3.93M
3.93M – 3.93M
-62.3% YoY
5.43M
5.43M – 5.43M
+37.9% YoY
11.53M
11.53M – 11.53M
+112.6% YoY
21.90M
21.90M – 21.90M
+89.9% YoY
66.90M
66.90M – 66.90M
+205.5% YoY
EBITDA
-20.68M
est: -103.7K (-19,831.7%)
-20.31M
est: -100.0K (-20,208.1%)
-19.76M
est: -100.0K (-19,657.6%)
-21.23M
est: -100.0K (-21,133.8%)
-16.55M
est: -88.0K (-18,710.4%)
-21.30M
est: -100.0K (-21,195.7%)
-20.88M
est: -91.7K (-22,678.2%)
-31.71M
est: -100.0K (-31,605.3%)
-17.90M
est: 12.5K (-143,328.5%)
-13.95M
est: 2.09M (-768.9%)
786.7K
786.7K – 786.7K
-62.3% YoY
1.08M
1.08M – 1.08M
+37.9% YoY
2.31M
2.31M – 2.31M
+112.6% YoY
4.38M
4.38M – 4.38M
+89.9% YoY
13.38M
13.38M – 13.38M
+205.5% YoY
EBIT
-21.10M
est: -103.7K (-20,241.3%)
-21.33M
est: -100.0K (-21,230.9%)
-20.31M
est: -100.0K (-20,210.6%)
-21.59M
est: -100.0K (-21,490.7%)
-17.27M
est: -88.0K (-19,530.5%)
-22.04M
est: -100.0K (-21,937.3%)
-21.58M
est: -91.7K (-23,445.1%)
-32.44M
est: -100.0K (-32,337.0%)
-18.62M
est: 12.5K (-149,073.9%)
-14.65M
est: 2.09M (-802.4%)
786.7K
786.7K – 786.7K
-62.3% YoY
1.08M
1.08M – 1.08M
+37.9% YoY
2.31M
2.31M – 2.31M
+112.6% YoY
4.38M
4.38M – 4.38M
+89.9% YoY
13.38M
13.38M – 13.38M
+205.5% YoY
Net Income
-22.46M
est: -190.84M (+88.2%)
-22.05M
est: -2.06B (+98.9%)
-20.40M
est: -309.86M (+93.4%)
-11.88M
est: -192.19M (+93.8%)
-16.85M
est: -157.52M (+89.3%)
-21.48M
est: -126.01M (+83.0%)
-20.77M
est: -39.13M (+46.9%)
-35.90M
est: -47.91M (+25.1%)
-18.62M
est: -46.66M (+60.1%)
-14.50M
est: -14.50M (+0.0%)
-7.06M
-8.49M – -5.64M
+51.3% YoY
-4.00M
-4.25M – -3.75M
+43.4% YoY
-4.41M
-5.73M – -3.09M
-10.2% YoY
-4.31M
-4.31M – -4.31M
+2.3% YoY
-3.51M
-3.51M – -3.51M
+18.5% YoY
SGA
6.69M
est: 6.89M (-3.0%)
6.53M
est: 6.64M (-1.8%)
5.89M
est: 6.64M (-11.3%)
9.70M
est: 6.64M (+46.0%)
8.00M
est: 5.85M (+36.8%)
7.64M
est: 6.64M (+15.0%)
10.89M
est: 6.09M (+78.8%)
13.69M
est: 6.64M (+106.0%)
7.49M
est: 651.9K (+1,049.4%)
6.87M
est: 108.78M (-93.7%)
41.03M
41.03M – 41.03M
-62.3% YoY
56.58M
56.58M – 56.58M
+37.9% YoY
120.30M
120.30M – 120.30M
+112.6% YoY
228.42M
228.42M – 228.42M
+89.9% YoY
697.79M
697.79M – 697.79M
+205.5% YoY
EPS
-2,821.30
est: -216.30 (-1,204.3%)
-2,328.26
est: -2,337.39 (+0.4%)
-532.22
est: -351.20 (-51.5%)
-132.23
est: -217.83 (+39.3%)
-151.01
est: -178.53 (+15.4%)
-131.51
est: -142.83 (+7.9%)
-748.77
est: -44.35 (-1,588.4%)
-65.55
est: -54.30 (-20.7%)
-21.10
est: -21.91 (+3.7%)
-6.83
est: -7.13 (+4.2%)
-3.33
-4.00 – -2.66
+53.2% YoY
-1.89
-2.00 – -1.77
+43.4% YoY
-1.93
-2.70 – -1.46
-2.1% YoY
-2.03
-2.03 – -2.03
-5.5% YoY
-1.66
-1.66 – -1.66
+18.5% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-05-12 B- 2/5 4/5 1/5 1/5 2/5 1/5 5/5
2026-05-11 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-08 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-07 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-06 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-05 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-04 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-24 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-23 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-22 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-21 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-20 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-17 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5
2026-04-16 C+ 2/5 4/5 1/5 1/5 2/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-4.00B
OE per share TTM
-797.68
Owner's Yield
-30,562.93%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
531.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
5
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 CVI Investments, Inc. 1.22M 8.50% 1.22M 1.22M CO Cayman Islands 2024-08-05
2 Heights Capital Management, Inc. 1.22M 8.50% 1.22M 1.22M CO Cayman Islands 2024-08-05
3 Capital LLC 1.05M 9.90% 1.05M 1.05M IA Delaware 2024-11-14
4 Khatri 1.05M 9.90% 1.05M 1.05M IN Delaware 2024-11-14
5 Opportunity Master Fund, SPC – Segregated Master Portfolio B 1.05M 9.90% 1.05M 1.05M CO Delaware 2024-11-14

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 ADVISOR GROUP HOLDINGS, INC. -14.0 (-100.0%) -11.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 15 qtrs SOLD
2 BAADER BANK AKTIENGESELLSCHAFT -21.6K (-100.0%) -10.7K (-100.0%) 0.00% -0.098 pp 0.00% -0.001 pp USD 2 qtrs SOLD
3 BANK OF AMERICA CORP /DE/ -415.0 (-100.0%) -332.0 (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD 8 qtrs SOLD
4 BLACKROCK, INC. -58.2K (-100.0%) -46.6K (-100.0%) 0.00% -0.264 pp 0.00% +0.000 pp USD 5 qtrs SOLD
5 CITIGROUP INC -11.6K (-100.0%) -9.3K (-100.0%) 0.00% -0.053 pp 0.00% +0.000 pp USD 4 qtrs SOLD
6 FEDERATION DES CAISSES DESJARDINS DU QUEBEC -66.0 (-100.0%) -53.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 15 qtrs SOLD
7 FMR LLC -501.0 (-100.0%) -401.0 (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD 3 qtrs SOLD
8 GAME PLAN FINANCIAL ADVISORS, LLC -2.0 (-100.0%) -2.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 8 qtrs SOLD
9 GEODE CAPITAL MANAGEMENT, LLC -144.7K (-100.0%) -115.8K (-100.0%) 0.00% -0.657 pp 0.00% +0.000 pp USD 15 qtrs SOLD
10 GROUP ONE TRADING, L.P. -129.0 (-100.0%) -103.0 (-100.0%) 0.00% -0.001 pp 0.00% +0.000 pp USD 15 qtrs SOLD
11 MORGAN STANLEY -1.6K (-100.0%) -1.3K (-100.0%) 0.00% -0.007 pp 0.00% +0.000 pp USD 15 qtrs SOLD
12 NORTHERN TRUST CORP -21.6K (-100.0%) -17.3K (-100.0%) 0.00% -0.098 pp 0.00% +0.000 pp USD 4 qtrs SOLD
13 RENAISSANCE TECHNOLOGIES LLC -638.0K (-100.0%) -510.4K (-100.0%) 0.00% -2.896 pp 0.00% -0.001 pp USD 15 qtrs SOLD
14 RIVERVIEW CAPITAL ADVISERS, LLC -11.7K (-100.0%) -9.4K (-100.0%) 0.00% -0.053 pp 0.00% -0.003 pp USD 2 qtrs SOLD
15 SABBY MANAGEMENT, LLC -900.0K (-100.0%) -720.0K (-100.0%) 0.00% -4.085 pp 0.00% -1.306 pp USD 2 qtrs SOLD
16 STATE STREET CORP -21.3K (-100.0%) -17.0K (-100.0%) 0.00% -0.097 pp 0.00% +0.000 pp USD 15 qtrs SOLD
17 TOWER RESEARCH CAPITAL LLC (TRC) -3.9K (-100.0%) -3.1K (-100.0%) 0.00% -0.018 pp 0.00% 0.000 pp USD 15 qtrs SOLD
18 TWO SIGMA INVESTMENTS, LP -29.6K (-100.0%) -23.7K (-100.0%) 0.00% -0.134 pp 0.00% +0.000 pp USD 2 qtrs SOLD
19 TWO SIGMA SECURITIES, LLC -12.9K (-100.0%) -10.3K (-100.0%) 0.00% -0.059 pp 0.00% -0.001 pp USD 2 qtrs SOLD
20 UBS GROUP AG -15.3K (-100.0%) -12.3K (-100.0%) 0.00% -0.070 pp 0.00% +0.000 pp USD 12 qtrs SOLD
21 VANGUARD GROUP INC -190.5K (-100.0%) -152.4K (-100.0%) 0.00% -0.865 pp 0.00% +0.000 pp USD 15 qtrs SOLD
22 VIRTU FINANCIAL LLC -41.1K (-100.0%) -33.0K (-100.0%) 0.00% -0.186 pp 0.00% -0.002 pp USD 2 qtrs SOLD
23 WELLS FARGO & COMPANY/MN -41.8K (-100.0%) -33.5K (-100.0%) 0.00% -0.190 pp 0.00% +0.000 pp USD 2 qtrs SOLD
24 XTX TOPCO LTD -29.4K (-100.0%) -23.5K (-100.0%) 0.00% -0.134 pp 0.00% -0.001 pp USD 4 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Extended Market ETF VXF 0.00% 100.1K 0.05%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
13
Sells
0
Shares acquired
21.2K
Shares disposed
Cash buys
Cash sales
Net activity
+21,185
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-01-15 CHURCH JEFFREY WAYNE Officer Common Stock 0 0.00 26 D
2026-01-02 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 43,821 3.95 173.1K 43,821 D
2026-01-02 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 4,827 3.95 19.1K 4,827 D
2026-01-02 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 56,187 3.95 221.9K 56,187 D
2026-01-02 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 5,892 3.95 23.3K 5,892 D
2026-01-02 Faller Douglas Vincent Officer A-Award A Stock Option (Right to Buy) 12,667 3.95 50.0K 12,667 D
2026-01-02 Eylward Susan Officer A-Award A Stock Option (Right to Buy) 8,251 3.95 32.6K 8,251 D
2026-01-02 Dentzer James E Director A-Award A Stock Option (Right to Buy) 4,405 3.95 17.4K 4,405 D
2026-01-02 CHURCH JEFFREY WAYNE Officer Stock Option (Right to Buy) 5,000 3.95 19.8K 0 D
2026-01-02 Braun Donald P Director A-Award A Stock Option (Right to Buy) 5,881 3.95 23.2K 5,881 D
2026-01-02 Bragg Kimberly Officer A-Award A Stock Option (Right to Buy) 9,050 3.95 35.7K 9,050 D
2026-01-02 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 15,736 3.95 62.2K 15,736 D
2025-09-06 Lindborg Stacy Director / Officer M-Exempt D Restricted Stock 1,667 0.00 0 D
2025-08-04 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 1,667 9.20 15.3K 1,667 D
2025-08-04 Pellizzari Christine A Director A-Award A Common Stock 2,248 9.20 20.7K 2,248 D
2025-08-04 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 5,000 9.20 46.0K 5,000 D
2025-08-04 Fritz Frederick J. Director A-Award A Common Stock 3,161 9.20 29.1K 3,946 D
2025-08-04 Eylward Susan Officer A-Award A Stock Option (Right to Buy) 417 9.20 3.8K 417 D
2025-08-04 Dentzer James E Director A-Award A Common Stock 3,318 9.20 30.5K 3,318 D
2025-08-04 CHURCH JEFFREY WAYNE Officer Stock Option (Right to Buy) 167 9.20 1.5K 0 D
2025-08-04 Braun Donald P Director A-Award A Common Stock 2,040 9.20 18.8K 3,747 D
2025-08-04 Bragg Kimberly Officer A-Award A Stock Option (Right to Buy) 667 9.20 6.1K 667 D
2025-08-04 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 1,667 9.20 15.3K 1,667 D
2025-06-13 Bragg Kimberly Officer Common Stock 0 0.00 18,400 I
2025-03-14 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 25,000 0.87 21.6K 25,000 D
2025-03-14 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 3,750 0.87 3.2K 3,750 D
2025-03-14 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 75,000 0.87 64.9K 75,000 D
2025-03-14 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 3,750 0.87 3.2K 3,750 D
2025-03-14 Eylward Susan Officer A-Award A Stock Option (Right to Buy) 6,250 0.87 5.4K 6,250 D
2025-03-14 Dentzer James E Director A-Award A Stock Option (Right to Buy) 3,750 0.87 3.2K 3,750 D
2025-03-14 Braun Donald P Director A-Award A Stock Option (Right to Buy) 3,750 0.87 3.2K 3,750 D
2025-03-14 Bragg Kimberly Officer Stock Option (Right to Buy) 10,000 0.87 8.7K 0 D
2025-02-18 Faller Douglas Vincent Officer 0 0.00 0
2024-12-18 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 12,500 0.83 10.4K 12,500 D
2024-10-07 Eylward Susan Officer A-Award A Stock Option (Right to Buy) 50,000 1.02 51.0K 50,000 D
2024-09-06 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 82,926 1.04 86.2K 394,759
2024-09-06 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 4,964 1.04 5.2K 23,630
2024-09-06 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 63,602 1.04 66.1K 302,768
2024-09-06 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 6,737 1.04 7.0K 32,070
2024-09-06 Dentzer James E Director A-Award A Stock Option (Right to Buy) 3,634 1.04 3.8K 17,301
2024-09-06 Braun Donald P Director A-Award A Option to purchase Imunon common stock 9,072 1.04 9.4K 28,905
2024-09-06 Bragg Kimberly Officer Stock Option (Right to Buy) 13,227 1.04 13.8K 0 D
2024-09-06 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 40,653 1.04 42.3K 173,486
2024-08-20 Braun Donald P Director P-Purchase A Common Stock 25,000 1.18 29.5K 25,597 D
2024-08-15 Tardugno Michael H Director / Officer P-Purchase A Imunon Common Stock 25,000 1.03 25.8K 353,346
2024-08-15 Lindborg Stacy Director / Officer P-Purchase A Imunon Common Stock 25,000 0.98 24.5K 264,166
2024-06-12 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 100,000 1.22 122.0K 328,346
2024-06-12 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 4,500 1.22 5.5K 18,666
2024-06-12 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 112,500 1.22 137.3K 239,166
2024-06-12 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 3,500 1.22 4.3K 37,099
2024-06-12 Dentzer James E Director A-Award A Stock Option (Right to Buy) 4,500 1.22 5.5K 13,667
2024-06-12 Braun Donald P Director A-Award A Option to purchase Imunon common stock 3,500 1.22 4.3K 23,430
2024-06-12 Bragg Kimberly Officer Stock Option (Right to Buy) 10,000 1.22 12.2K 0 D
2024-06-12 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 25,000 1.22 30.5K 135,688
2024-06-01 Gaiero David G Officer D Common Stock 0 0.00 0
2024-05-13 Lindborg Stacy Director / Officer A-Award A Stock Option (Right to Buy) 112,500 1.48 166.5K 126,666
2024-03-15 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 12,500 0.86 10.8K 228,346
2024-03-15 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 4,500 0.86 3.9K 14,166
2024-03-15 Lindborg Stacy Director A-Award A Stock Option (Right to Buy) 4,500 0.86 3.9K 14,166
2024-03-15 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 3,500 0.86 3.0K 33,599
2024-03-15 Dentzer James E Director A-Award A Stock Option (Right to Buy) 4,500 0.86 3.9K 9,167
2024-03-15 CHURCH JEFFREY WAYNE Officer A-Award A Stock Option (Right to Buy) 25,000 0.86 21.5K 120,950
2024-03-15 Braun Donald P Director A-Award A Option to purchase Imunon common stock 3,500 0.86 3.0K 19,930
2024-03-15 Bragg Kimberly Officer Stock Option (Right to Buy) 10,000 0.86 8.6K 0 D
2024-03-15 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 25,000 0.86 21.5K 110,688
2024-03-14 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 25,000 0.87 21.6K 25,000 D
2023-12-07 Hazard Sebastien Officer D Common Stock 0 0.00 0
2023-10-17 Bragg Kimberly Officer Stock Option (Right to Buy) 10,000 1.40 14.0K 0 D
2023-03-17 Tardugno Michael H Director / Officer A-Award A Stock Option (Right to Buy) 25,000 1.32 33.0K 215,846
2023-03-17 Pellizzari Christine A Director A-Award A Stock Option (Right to Buy) 2,000 1.32 2.6K 9,666
2023-03-17 Lindborg Stacy Director A-Award A Stock Option (Right to Buy) 2,000 1.32 2.6K 9,666
2023-03-17 Le Goff Corinne Director / Officer A-Award A Stock Option (Right to Buy) 90,000 1.32 118.8K 320,000
2023-03-17 Fritz Frederick J. Director A-Award A Stock Option (Right to Buy) 2,000 1.32 2.6K 30,099
2023-03-17 Dentzer James E Director A-Award A Stock Option (Right to Buy) 2,000 1.32 2.6K 4,667
2023-03-17 Chow Pok Yu Augustine Director A-Award A Stock Option (Right to Buy) 2,000 1.32 2.6K 18,429
2023-03-17 CHURCH JEFFREY WAYNE Officer A-Award A Stock Option (Right to Buy) 40,000 1.32 52.8K 95,950
2023-03-17 Braun Donald P Director A-Award A Option to purchase Imunon common stock 2,000 1.32 2.6K 16,430
2023-03-17 Bragg Kimberly Officer Stock Option (Right to Buy) 7,500 1.32 9.9K 0 D
2023-03-17 Anwer Khursheed Officer A-Award A Stock Option (Right to Buy) 40,000 1.32 52.8K 85,688
2022-09-30 Dentzer James E Director A-Award A Option (right to buy) 2,667 0.00 2,667
2022-09-29 Dentzer James E Director D Common Stock 0 0.00 0
2022-07-18 Le Goff Corinne Director / Officer D Common Stock 0 0.00 0
2022-06-13 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 29,300
2022-06-13 Tardugno Michael H Officer A-Award A Option to Purchase Celsion Common Stock 90,000 0.00 303,068
2022-06-13 Pellizzari Christine A Director A-Award A Option to Purchase Celsion Common Stock 2,500 0.00 7,666
2022-06-13 Lindborg Stacy Director A-Award A Option to Purchase Celsion Common Stock 2,500 1.93 4.8K 7,666
2022-06-13 Kardaras Constantine John Officer A-Award A Option to Purchase Celsion Common Stock 1,750 0.00 5,833
2022-06-13 Hooper Robert W Director A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 26,978
2022-06-13 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 27,004
2022-06-13 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 27,242
2022-06-13 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Common Stock 50,000 0.00 97,659
2022-06-13 Braun Donald P Director A-Award A Option to Purchase Celsion Common Stock 6,250 0.00 22,587
2022-04-12 Tardugno Michael H Director / Officer P-Purchase A Celsion Corporation Common Stock 4,000 3.53 14.1K 16,513
2022-04-08 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 5,000 4.05 20.3K 11,766
2022-03-04 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Common Stock 7,500 4.60 34.5K 21,800
2022-03-04 Tardugno Michael H Officer A-Award A Option to Purchase Celsion Common Stock 80,000 0.00 213,068
2022-03-04 Pellizzari Christine A Director A-Award A Option to Purchase Celsion Corporation Common Stock 2,500 0.00 5,166
2022-03-04 Lindborg Stacy Director A-Award A Option to Purchase Celsion Corporation Common Stock 2,500 0.00 5,166
2022-03-04 Kardaras Constantine John Officer A-Award A Option to Purchase Celsion Common Stock 1,750 0.00 4,083
2022-03-04 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 7,500 4.60 34.5K 19,478
2022-03-04 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 19,504
2022-03-04 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Common Stock 7,500 0.00 19,742
2022-03-04 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,250 0.00 16,337
2022-03-02 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 2,000 4.69 9.4K 6,766
2021-12-14 Kardaras Constantine John Officer D Celsion Corporation Common Stock 0 0.00 0
2021-10-07 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 20,000 0.88 17.6K 71,491
2021-06-09 Pellizzari Christine A Director D Celsion Corporation Common Stock 0 0.00 0
2021-06-08 Pellizzari Christine A Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 1.25 50.0K 40,000
2021-06-04 Lindborg Stacy Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 1.24 49.6K 40,000
2021-05-17 Braun Donald P Director P-Purchase A Celsion Corporation Common Stock 5,000 1.07 5.4K 5,357
2021-03-19 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 2.24 89.6K 151,357
2021-03-19 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 65,000 2.24 145.6K 214,557
2021-03-19 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 650,000 2.24 1.46M 1,996,071
2021-03-19 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 2.24 89.6K 179,737
2021-03-19 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 2.24 89.6K 180,118
2021-03-19 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 2.24 89.6K 183,689
2021-03-19 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Corporation Common Stock 275,000 2.24 616.0K 714,951
2021-03-19 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 40,000 2.24 89.6K 151,357
2020-06-15 Voss Andreas Director D-Return D Option to Purchase Celsion Corporation Common Stock 50,000 2.22 111.0K 61,357
2020-06-15 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 80,000 2.58 206.4K 149,557
2020-06-15 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 850,000 2.58 2.19M 1,346,071
2020-06-15 Martinez Alberto R Jr Director D-Return D Option to Purchase Celsion Corporation Common Stock 70,000 2.22 155.4K 69,880
2020-06-15 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 4,000 3.66 14.6K 139,737
2020-06-15 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 4,000 3.66 14.6K 140,118
2020-06-15 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 70,000 2.58 180.6K 143,689
2020-06-15 CHURCH JEFFREY WAYNE Officer D-Return D Option to Purchase Celsion Corporation Common Stock 250,000 2.22 555.0K 189,951
2020-06-15 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 4,000 3.66 14.6K 111,357
2020-02-28 Martinez Alberto R Jr Director P-Purchase A Celsion Corporation Common Stock 5,000 0.90 4.5K 45,000
2020-02-25 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 6,000.00 36.00M 107,357
2020-02-25 Tumminello Timothy J Officer A-Award A Celsion Corporation Common Stock 14,500 1.16 16.8K 15,258
2020-02-25 Tardugno Michael H Director / Officer A-Award A Celsion Corporation Common Stock 155,000 1.16 179.8K 187,700
2020-02-25 Martinez Alberto R Jr Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 1.16 7.0K 135,880
2020-02-25 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 1.16 7.0K 135,737
2020-02-25 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 1.16 7.0K 136,118
2020-02-25 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 1.16 7.0K 139,689
2020-02-25 CHURCH JEFFREY WAYNE Officer A-Award A Celsion Corporation Common Stock 47,000 1.16 54.5K 54,298
2020-02-25 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 6,000 1.16 7.0K 107,357
2019-11-20 Martinez Alberto R Jr Director P-Purchase A Celsion Corporation Common Stock 6,000 1.42 8.5K 40,000
2019-11-06 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 10,000 1.39 13.9K 51,491
2019-11-04 Martinez Alberto R Jr Director P-Purchase A Celsion Corporation Common Stock 4,000 1.61 6.4K 34,000
2019-10-03 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 101,357
2019-10-03 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 1.72 17.2K 124,557
2019-10-03 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 65,000 1.72 111.8K 1,211,071
2019-10-03 Martinez Alberto R Jr Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 129,880
2019-10-03 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 129,737
2019-10-03 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 130,118
2019-10-03 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 133,689
2019-10-03 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Corporation Common Stock 35,000 1.72 60.2K 384,951
2019-10-03 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 14,000 1.72 24.1K 101,357
2019-08-02 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 10,000 1.73 17.3K 41,491
2019-07-25 Martinez Alberto R Jr Director P-Purchase A Celsion Corporation Common Stock 6,000 1.76 10.6K 30,000
2019-07-24 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 10,000 1.73 17.3K 31,491
2019-06-19 CHURCH JEFFREY WAYNE Officer P-Purchase A Celsion Corporation Common Stock 5,000 1.89 9.5K 7,298
2019-05-16 Tardugno Michael H Director / Officer P-Purchase A Celssion Corporation Common Stock 5,000 2.16 10.8K 32,700
2019-05-16 Martinez Alberto R Jr Director P-Purchase A Celssion Corporation Common Stock 4,000 2.15 8.6K 24,000
2019-05-14 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 87,357
2019-05-14 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 7,500 2.14 16.1K 114,557
2019-05-14 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 50,000 2.14 107.0K 1,146,071
2019-05-14 Martinez Alberto R Jr Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 115,880
2019-05-14 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 116,118
2019-05-14 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 116,118
2019-05-14 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 119,689
2019-05-14 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Corporation Common Stock 25,000 2.14 53.5K 349,951
2019-05-14 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 10,000 2.14 21.4K 87,357
2019-03-06 Fritz Frederick J. Director P-Purchase A Celssion Corporation Common Stock 3,400 2.13 7.2K 21,491
2019-02-19 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 77,357
2019-02-19 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 7,500 2.18 16.4K 107,057
2019-02-19 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 50,000 2.18 109.0K 1,096,071
2019-02-19 Martinez Alberto R Jr Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 105,880
2019-02-19 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 106,118
2019-02-19 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 106,118
2019-02-19 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 109,689
2019-02-19 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Corporation Common Stock 20,000 2.18 43.6K 324,951
2019-02-19 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,000 2.18 26.2K 77,357
2019-02-19 Borys Nicholas Officer A-Award A Option to Purchase Celsion Corporation Common Stock 20,000 2.18 43.6K 325,047
2018-10-29 Tardugno Michael H Director / Officer P-Purchase A Celsion Corporation Common Stock 7,500 2.06 15.5K 27,700
2018-10-03 Hooper Robert W Director P-Purchase A Celsion Corporation Common Stock 4,900 2.70 13.2K 25,687
2018-10-02 Hooper Robert W Director P-Purchase A Celsion Corporation Common Stock 5,100 2.70 13.8K 20,787
2018-09-20 Fritz Frederick J. Director P-Purchase A Celssion Corporation Common Stock 2,500 2.70 6.8K 18,091
2018-08-15 Fritz Frederick J. Director P-Purchase A Celssion Corporation Common Stock 2,750 2.37 6.5K 15,591
2018-05-15 Voss Andreas Director J-Other A Celsion Corporation Common Stock 6,250 2.24 14.0K 6,607
2018-05-15 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 80,000 2.22 177.6K 99,557
2018-05-15 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 850,000 2.22 1.89M 1,046,071
2018-05-15 Martinez Alberto R Jr Director A-Award A Option to Purchase Celsion Corporation Common Stock 70,000 2.22 155.4K 93,880
2018-05-15 Hooper Robert W Director A-Award A Option to Purchase Celsion Corporation Common Stock 70,000 2.22 155.4K 94,118
2018-05-15 Fritz Frederick J. Director A-Award A Option to Purchase Celsion Corporation Common Stock 70,000 2.22 155.4K 94,118
2018-05-15 Chow Pok Yu Augustine Director A-Award A Option to Purchase Celsion Corporation Common Stock 70,000 2.22 155.4K 97,689
2018-05-15 CHURCH JEFFREY WAYNE Officer A-Award A Option to Purchase Celsion Corporation Common Stock 250,000 2.22 555.0K 304,951
2018-05-15 Braun Donald P Director A-Award A Option to Purchase Celsion Corporation Common Stock 50,000 2.22 111.0K 65,357
2018-05-15 Borys Nicholas Officer A-Award A Option to Purchase Celsion Corporation Common Stock 250,000 2.22 555.0K 305,047
2018-05-15 Anwer Khursheed Officer A-Award A Option to Purchase Celsion Corporation Common Stock 100,000 2.22 222.0K 124,643
2018-04-09 Tardugno Michael H Director / Officer P-Purchase A Celsion Corporation Common Stock 2,500 2.30 5.8K 20,200
2018-03-05 Tardugno Michael H Director / Officer P-Purchase A Celsion Corporation Common Stock 7,500 2.38 17.8K 17,700
2018-02-22 Martinez Alberto R Jr Director P-Purchase A Celsion Corporation Common Stock 7,143 2.17 15.5K 20,000
2018-02-20 Hooper Robert W Director P-Purchase A Celsion Corporation Common Stock 13,625 2.18 29.7K 15,687
2018-02-20 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 3,000 2.17 6.5K 12,841
2017-07-07 Fritz Frederick J. Director P-Purchase A Celsion Corporation Common Stock 6,500 1.88 12.2K 9,841
2017-05-30 Voss Andreas Director A-Award A Option to Purchase Celsion Corporation Common Stock 12,500 2.69 33.6K 12,500
2017-05-30 Tumminello Timothy J Officer A-Award A Option to Purchase Celsion Corporation Common Stock 17,143 2.69 46.1K 17,143
2017-05-30 Tardugno Michael H Director / Officer A-Award A Option to Purchase Celsion Corporation Common Stock 176,429 2.69 474.6K 176,429

Executive team

Top executives
Shares Outstanding
2.52M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Stacy Lindborg President & CEO 568.1K 104.0K 357.2K 1.03M 10.10%
2 2025 Michael Tardugno Executive Chairman & former interim CEO 350.7K 34.7K 210.0K 10.6K 605.9K 5.72%
3 2025 Douglas Faller, MD Chief Medical Officer 387.7K 76.9K 113.4K 11.8K 589.8K 13.03%
4 2024 Stacy Lindborg President & CEO 342.0K 26.5K 335.6K 283.5K 201.7K 1.19M 30.45%
5 2024 Michael Tardugno Executive Chairman & former interim CEO 336.6K 213.1K 175.0K 10.1K 734.8K 29.00%
6 2023 Corinne Le Goff President CEO 658.1K 107.8K 275.0K 15.0K 1.06M 10.21%
7 2023 Khursheed Anwer Executive VP CSO 412.8K 47.9K 125.3K 94.2K 680.2K 7.04%
8 2023 Jeffrey Church Executive VP CFO 441.3K 47.9K 115.7K 75.0K 679.9K 7.04%
9 2022 Michael H. Tardugno Executive Chairman 573.6K 506.5K 382.7K 622.5K 2.09M 24.29%
10 2022 Corinne Le Goff President CEO 264.0K 97.5K 308.6K 157.3K 56.5K 883.8K 45.95%
11 2022 Corinne Le Goff President CEO 264.0K 97.5K 308.6K 157.3K 56.5K 883.8K 45.95%
12 2022 Nicholas Borys Executive VP CMO 445.3K 118.3K 131.0K 12.5K 707.1K 16.73%
13 2022 Khursheed Anwer Executive VP CSO 382.6K 19.5K 118.3K 139.7K 18.5K 678.7K 20.30%
14 2022 Jeffrey Church Executive VP CFO 409.8K 87.7K 139.1K 636.6K 13.78%
15 2021 Michael H. Tardugno Executive Chairman 581.6K 1.32M 381.3K 48.0K 2.31M 57.18%
16 2021 Jeffrey Church Executive VP CFO 397.0K 559.4K 117.0K 14.5K 1.09M 51.42%
17 2021 Khursheed Anwer Executive VP CSO 362.9K 508.6K 120.5K 28.6K 1.02M 49.83%
18 2021 Nicholas Borys Executive VP CMO 432.4K 203.4K 127.2K 27.0K 789.9K 25.75%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-05-04 DEF 14A
2025-06-09 DEF 14A
2025-05-30 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-12 8-K
2026-05-12 10-Q
2026-05-04 DEF 14A
2026-05-04 ARS
2026-05-04 8-K
2026-03-31 8-K
2026-03-31 10-K
2026-03-23 8-K
2026-03-23 424B5
2026-02-17 SC 13G

Executive team

NameTitleCompensationGender
Stacy R. Lindborg President, Chief Executive Officer & Director 925.3K
Jeffrey W. Church Chief Financial Officer 798.2K male
Michael H. Tardugno Executive Chairman 571.2K male
Douglas V. Faller Chief Medical Officer 559.5K
Timothy J. Tumminello Chief Accounting Officer & Controller 108.3K male
Kristin Longobardi Senior Vice President of Strategic Operations female
Susan Mary Eylward General Counsel & Corporate Secretary female
ESG Rating
B-
BIOTECHNOLOGY
Rank: 614 out of 662
2026
E (Environmental)
57.1 / 56.3
Company / Sector avg.
S (Social)
55.8 / 62.4
Company / Sector avg.
G (Governance)
56.5 / 60.9
Company / Sector avg.
ESG Total
56.5 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits